BioCryst Pharma (BCRX) Reports Q4 Loss of $0.40/sh

Go back to BioCryst Pharma (BCRX) Reports Q4 Loss of $0.40/sh
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.81 -0.78 (7.37%)
Previous Close $10.59    52 Week High $10.98 
Open $10.59    52 Week Low $1.63 
Day High $10.63    P/E N/A 
Day Low $9.70    EPS $-0.68 
Volume 4,580,196